FDA.reportPublic FDA data

Application 219014

Type
NDA
Sponsor
AVYXA HOLDINGS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BENDAMUSTINE HYDROCHLORIDEBENDAMUSTINE HYDROCHLORIDESOLUTION;INTRAVENOUS100MG/4ML (25MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82747ORIG 2025-07-08
82744ORIG 2025-07-08